U.S. biotech stocks are off to a strong start this week. It didn’t take long for investors to get over the Fed’s...
Markets are off to a good, but cautious start this week. The S&P 500 eked out a fresh record for the third...
Tuesday was a sea of red in the OTC Markets. Most of the recent high flyers all gave up ground. Unfortunately, we...
Last week’s negative FDA advisory committee vote may be the final nail in the coffin in the up-and-down registration path of Biogen...
AVXL stock was a big winner for us here at Insider Financial back in 2015 when we caught the run from $1 to...
Anavex Life Sciences Corp. (NASDAQ:AVXL) is a company that we’ve looked at on a number of occasions over the past twelve months...
During the middle of last week, Anavex Life Sciences Corp. (NASDAQ:AVXL) bottomed out on a two-day decline that saw it fall from...
Anavex Life Sciences Corp. (NASDAQ:AVXL) is a stock that we cover pretty regularly here at Insider Financial. The company is a biotechnology...
Anavex Life Sciences Corp. (NASDAQ:AVXL) has had a tough final couple of weeks of September. The company has been one of our...
Back on August 15, we published this piece detailing our thoughts on Anavex Life Sciences Corp. (NASDAQ:AVXL). At the time, the company...